These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23830193)

  • 1. A quality control model that uses PTV-rectal distances to predict the lowest achievable rectum dose, improves IMRT planning for patients with prostate cancer.
    Wang Y; Zolnay A; Incrocci L; Joosten H; McNutt T; Heijmen B; Petit S
    Radiother Oncol; 2013 Jun; 107(3):352-7. PubMed ID: 23830193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
    Moore KL; Brame RS; Low DA; Mutic S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A knowledge-based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: an example application to prostate cancer planning.
    Good D; Lo J; Lee WR; Wu QJ; Yin FF; Das SK
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):176-81. PubMed ID: 23623460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection.
    Yang Y; Ford EC; Wu B; Pinkawa M; van Triest B; Campbell P; Song DY; McNutt TR
    Med Phys; 2013 Jan; 40(1):011709. PubMed ID: 23298079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric advantage and clinical implication of a micro-multileaf collimator in the treatment of prostate with intensity-modulated radiotherapy.
    Wang L; Hoban P; Paskalev K; Yang J; Li J; Chen L; Xiong W; Ma CC
    Med Dosim; 2005; 30(2):97-103. PubMed ID: 15922176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I; Dirkx ML; Heijmen BJ
    Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting dose-volume histograms for organs-at-risk in IMRT planning.
    Appenzoller LM; Michalski JM; Thorstad WL; Mutic S; Moore KL
    Med Phys; 2012 Dec; 39(12):7446-61. PubMed ID: 23231294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intensity-modulated radiotherapy and forward-planning dynamic arc therapy techniques for prostate cancer.
    Metwaly M; Awaad AM; El-Sayed EM; Sallam ASM
    J Appl Clin Med Phys; 2008 Oct; 9(4):37-56. PubMed ID: 19020481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of plan quality assurance models for prostate cancer patients based on fully automatically generated Pareto-optimal treatment plans.
    Wang Y; Breedveld S; Heijmen B; Petit SF
    Phys Med Biol; 2016 Jun; 61(11):4268-82. PubMed ID: 27203748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.
    Guckenberger M; Meyer J; Baier K; Vordermark D; Flentje M
    Radiat Oncol; 2006 Sep; 1():34. PubMed ID: 16956403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of database quality in knowledge-based treatment planning for prostate cancer.
    Wall PDH; Carver RL; Fontenot JD
    Pract Radiat Oncol; 2018; 8(6):437-444. PubMed ID: 29730280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?
    Sanguineti G; Cavey ML; Endres EJ; Brandon GG; Bayouth JE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):151-60. PubMed ID: 16198066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implementation of a knowledge based planning tool for prostate VMAT.
    Powis R; Bird A; Brennan M; Hinks S; Newman H; Reed K; Sage J; Webster G
    Radiat Oncol; 2017 May; 12(1):81. PubMed ID: 28482845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer.
    Pinkawa M; Corral NE; Caffaro M; Piroth MD; Holy R; Djukic V; Otto G; Schoth F; Eble MJ
    Radiother Oncol; 2011 Sep; 100(3):436-41. PubMed ID: 21963289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
    Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
    Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only?
    Guckenberger M; Baier K; Richter A; Vordermark D; Flentje M
    Radiat Oncol; 2008 Jan; 3():3. PubMed ID: 18190681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is ad-hoc plan adaptation based on 2-Step IMRT feasible?
    Bratengeier K; Polat B; Gainey M; Grewenig P; Meyer J; Flentje M
    Radiother Oncol; 2009 Nov; 93(2):266-72. PubMed ID: 19796833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.